Epigenetic Drug Discovery (Drug Discovery Volume 83) 1St Edition at Meripustak

Epigenetic Drug Discovery (Drug Discovery Volume 83) 1St Edition

Books from same Author: Ho Man Chan & Cheryl H Arrowsmith

Books from same Publisher: Rsc

Related Category: Author List / Publisher List


  • Retail Price: ₹ 23641/- [ 7.00% off ]

    Seller Price: ₹ 21986

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 7.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 7.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s) Ho Man Chan & Cheryl H Arrowsmith
    PublisherRsc
    Edition1st Edition
    ISBN9781837671106
    Pages696
    BindingHardcover
    Publish YearSeptember 2024

    Description

    Rsc Epigenetic Drug Discovery (Drug Discovery Volume 83) 1St Edition by Ho Man Chan & Cheryl H Arrowsmith

    Epigenetics is one of the fastest moving fields in drug discovery, with almost every large pharmaceutical company, and a substantial number of biotechnology companies, targeting epigenetic processes to treat diseases ranging from cancer to Huntington’s disease and from inflammation to sickle cell anaemia. This book aims to provide an overview of the key topics adopted in current epigenetic drug discovery programmes with a focus on major developments and new technologies. Importantly, the book incorporates case studies and outlines the key challenges and techniques employed to overcome them. The book is an ideal resource for researchers in both industry and academia with an interest in epigenetic and genetic factors involved in drug discovery, target ID and validation. The book is also an excellent introduction for postgraduates interested in the interface between epigenetics and pharmaceuticals.